Phoenix Retina Clinical Trials, LLC - North Phoenix — Phoenix, Arizona

Phoenix Retina Clinical Trials, LLC - North Phoenix is a clinical research site located in Phoenix, Arizona, United States 85050.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Phoenix Retina Clinical Trials, LLC - North Phoenix has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Macular Edema, DME, Diabetic Macular Edema (DME).

Sponsors: EyePoint Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Phoenix Retina Clinical Trials, LLC - North Phoenix?

Phoenix Retina Clinical Trials, LLC - North Phoenix has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Phoenix Retina Clinical Trials, LLC - North Phoenix conducted?

Phoenix Retina Clinical Trials, LLC - North Phoenix has 1 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema, DME, Diabetic Macular Edema (DME).

Is Phoenix Retina Clinical Trials, LLC - North Phoenix accredited by Crixeo Clinical Trials?

Phoenix Retina Clinical Trials, LLC - North Phoenix has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Phoenix Retina Clinical Trials, LLC - North Phoenix?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.